期刊文献+

持续静脉滴注速尿对严重充血性心力衰竭患者心功能及利尿效果的影响 被引量:2

下载PDF
导出
摘要 目的 探讨持续静脉滴注速尿的利尿效果及改善心功能情况是否优于间断注射方法。方法 随机将 43例NYHA心功能Ⅲ~Ⅳ级患者分为持续静脉滴注组和间断注射组 ,比较两组 2 4h总尿量、尿电解质及超声心动图心功能指标的差别。结果 ①静滴组 2 4h尿量及尿K+ 、Na+ 、Cl 排泄量显著增加 ,尤以治疗第 2、3日为甚。而且 40mg/d静滴治疗尿量及电解质排出量显著 >静推组 ,但电解质相对无尿量显著 ;②在改善心功能指标SF、LVESV及LVEP方面只有静滴组有统计学意义。
出处 《四川医学》 CAS 2003年第6期586-587,共2页 Sichuan Medical Journal
基金 2000年成都市卫生局科研基金资助课题(编号2000-35)
  • 相关文献

参考文献7

  • 1曾朝荣,陈维永,刘璟瑜.高血压与左心室肥厚[J].中国心血管杂志,2002,7(1):54-56. 被引量:17
  • 2H Knauf, E Mutschler. Sequential nephron blockade breaks resistance to diuretics in edematous states. Journal of Cardiovascular Pharmacology, 1997,29: 367 - 372.
  • 3Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cantiolgy,2001,96(3 - 4) : 132 - 143.
  • 4Schuller D, Lynch JP, Fine D. Protocol quided diuretic management: comparision furosemide by continuous infusion and intermittent bolus. Crit Care Med,1997,25(2) : 1969 - 1975.
  • 5Gray JMB, Henry DA, Lawson DH, et al. Continuous infusion of furosemide in refratory oedema.Proceedings of the B P S, 1978,453.
  • 6Lahav M, Regev A, Raanani P . et al. Intermittent administration of hrosemide vs continuous infusion preceded by a loading dose for congestive heart failure.Chest, 1992,102:725 - 731.
  • 7Dormans TP, Joseph J M, Gerlag PG, et al. Diuretic efficacy of high dose furosemide in severe heart failure : bolus injection versus continuous infusion.JACC, 1996,28: 376 - 382.

二级参考文献17

  • 1Savage DD,Garrison R J,Kannel W B,et al, The Spectrum of left ventricular hypertrophy in a general population sample The Framingham study. Ciculation.1987,75(suppl I ):126-133.
  • 2Devereux R B,Koren M J,simone G D.et al. Methods for detection of left ventricular hyperophy: application to hypertensiveheart disease. Eur heart J, 1993,14(suppl. D) :8-15.
  • 3Qkin P M,Roman M J,Devereux R B,et al. Time-voltage QRS area of the 12-lead electrocardiogram detection of left ventricular hypertrophy. Hypertension, 1998,31 : 937-942.
  • 4Qkin P M,Jern S,Devereux R B.et al. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients. The losartan intervention for endpoint(LIFE) reduction in hypertension study. Hypertension, 2000,35 : 13-18.
  • 5Van-Zwieten PA. The influence of antihypertensive drug treatment on the prevention and regression of left ventrieular hypertrophy. Cardiovasc Res, 2000 . 45 : 82-91.
  • 6Deverrux R B, Therapeutic options in minimizing left ventricular hypertrophy, Am Heart J, 2000,139:S3-S14.
  • 7Pooh E,Goazalez D,Angelats G A.et al. G-protein β3 subunit Gene variant and left ventricular hypertrophy in essential hypertension. Hypertension, 2000,35(part 2) :214-218.
  • 8Wu-S, Hong-J, Li-H, et al. No correlation of polymorphism of angiotensin converting enzyme genes with left ventricular hypertrophy in essential hypertension. Hypertens Res, 2000.23 261-264.
  • 9Nakayama T.Soma M.Takahashi Y.et al. Functional deletion mutation, of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res,2000,86:841-845.
  • 10Suzuki M ,Yamamoto K,Watanabe S.et al. Association between elevated brain natriuretic peptide levels and the development of left ventrieular hypertrophy in patients with hypertensiort. Am J Med, 2000,108 : 627- 633.

共引文献16

同被引文献13

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部